drugset / Trial / NCT00126789
Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety of the matrix fentanyl patch ZR-02-01 in providing relief of cancer pain.
Timeline
- Start
- 2005-08
- Primary completion
- 2007-07
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | 25 ug | Other |
| Subject | Fentanyl | Other / unclassified | 50 ug | Other |
| Subject | Fentanyl | Other / unclassified | 75 ug | Other |
| Subject | Fentanyl | Other / unclassified | 100 ug | Other |